scholarly journals Advancing the Role of Neuroimmunity and Genetic Susceptibility in Gulf War Illness

EBioMedicine ◽  
2017 ◽  
Vol 26 ◽  
pp. 11-12 ◽  
Author(s):  
James P. O'Callaghan ◽  
Lindsay T. Michalovicz ◽  
Julie V. Miller ◽  
Kimberly A. Kelly
2020 ◽  
Vol 14 ◽  
Author(s):  
Jun Gao ◽  
Fuyi Xu ◽  
Athena Starlard-Davenport ◽  
Diane B. Miller ◽  
James P. O’Callaghan ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (9) ◽  
pp. e0184832 ◽  
Author(s):  
Yang Chen ◽  
Joel N. Meyer ◽  
Helene Z. Hill ◽  
Gudrun Lange ◽  
Michael R. Condon ◽  
...  

2021 ◽  
Vol 11 (7) ◽  
pp. 905
Author(s):  
Punnag Saha ◽  
Peter T. Skidmore ◽  
LaRinda A. Holland ◽  
Ayan Mondal ◽  
Dipro Bose ◽  
...  

Gulf War Illness (GWI) is a chronic multi-symptomatic illness that is associated with fatigue, pain, cognitive deficits, and gastrointestinal disturbances and presents a significant challenge to treat in clinics. Our previous studies show a role of an altered Gut–Brain axis pathology in disease development and symptom persistence in GWI. The present study utilizes a mouse model of GWI to study the role of a labdane diterpenoid andrographolide (AG) to attenuate the Gut–Brain axis-linked pathology. Results showed that AG treatment in mice (100 mg/kg) via oral gavage restored bacteriome alterations, significantly increased probiotic bacteria Akkermansia, Lachnospiraceae, and Bifidobacterium, the genera that are known to aid in preserving gut and immune health. AG also corrected an altered virome with significant decreases in virome families Siphoviridae and Myoviridae known to be associated with gastrointestinal pathology. AG treatment significantly restored tight junction proteins that correlated well with decreased intestinal proinflammatory mediators IL-1β and IL-6 release. AG treatment could restore Claudin-5 levels, crucial for maintaining the BBB integrity. Notably, AG could decrease microglial activation and increase neurotrophic factor BDNF, the key to neurogenesis. Mechanistically, microglial conditioned medium generated from IL-6 stimulation with or without AG in a concentration similar to circulating levels found in the GWI mouse model and co-incubated with neuronal cells in vitro, decreased Tau phosphorylation and neuronal apoptosis. In conclusion, we show that AG treatment mitigated the Gut–Brain-Axis associated pathology in GWI and may be considered as a potential therapeutic avenue for the much-needed bench to bedside strategies in GWI.


2020 ◽  
Vol 15 ◽  
pp. 263310552097984
Author(s):  
Kristin F Phillips ◽  
Laxmikant S Deshpande

Gulf War Illness (GWI) refers to a multi-system disorder that afflicts approximately 30% of First Gulf War (GW) veterans. Amongst the symptoms exhibited, mood and memory impairment are commonly reported by GW veterans. Exposure to organophosphate (OP) compounds which target the cholinergic system is considered a leading cause for GWI symptoms. It is hypothesized that chronic OP-based war-time stimulation of cholinergic signaling led to recruitment of excitatory glutamatergic signaling and other downstream signaling cascades leading to neuronal injury, neuroinflammation, generation of reactive oxygen species, oxidative stress, and mitochondrial damage within the central nervous system. These findings have been observed in both experimental models and GWI veterans. In this context the role of calcium (Ca2+) signaling in GWI has come to the forefront. Here we present our Ca2+ hypothesis of GWI that suggests sustained neuronal Ca2+ elevations serve as a molecular trigger for pathological synaptic plasticity that has allowed for the persistence of GWI symptoms. Subsequently we discuss that therapeutic targeting of Ca2+ homeostatic mechanisms provides novel targets for effective treatment of GWI-related neurological signs in our rodent model.


2021 ◽  
Vol 16 ◽  
pp. 263310552110184
Author(s):  
Aurore Nkiliza ◽  
Utsav Joshi ◽  
James E Evans ◽  
Ghania Ait-Ghezala ◽  
Megan Parks ◽  
...  

Gulf War Illness is a multisymptomatic condition which affects 30% of veterans from the 1991 Gulf War. While there is evidence for a role of peripheral cellular and humoral adaptive immune responses in Gulf War Illness, a potential role of the adaptive immune system in the central nervous system pathology of this condition remains unknown. Furthermore, many of the clinical features of Gulf War Illness resembles those of autoimmune diseases, but the biological processes are likely different as the etiology of Gulf War Illness is linked to hazardous chemical exposures specific to the Gulf War theatre. This review discusses Gulf War chemical–induced maladaptive immune responses and a potential role of cellular and humoral immune responses that may be relevant to the central nervous system symptoms and pathology of Gulf War Illness. The discussion may stimulate investigations into adaptive immunity for developing novel therapies for Gulf War Illness.


2020 ◽  
Vol 80 ◽  
pp. 60-70 ◽  
Author(s):  
Michelle R. Joyce ◽  
Kathleen F. Holton

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Carla Garza-Lombó ◽  
Morrent Thang ◽  
Hendrik J. Greve ◽  
Christen L. Mumaw ◽  
Evan J. Messenger ◽  
...  

AbstractGulf War Illness (GWI) is a chronic, multi-symptom peripheral and CNS condition with persistent microglial dysregulation, but the mechanisms driving the continuous neuroimmune pathology are poorly understood. The alarmin HMGB1 is an autocrine and paracrine pro-inflammatory signal, but the role of circulating HMGB1 in persistent neuroinflammation and GWI remains largely unknown. Using the LPS model of the persistent microglial pro-inflammatory response, male C57Bl/6J mice injected with LPS (5 mg/kg IP) exhibited persistent changes in microglia morphology and elevated pro-inflammatory markers in the hippocampus, cortex, and midbrain 7 days after LPS injection, while the peripheral immune response had resolved. Ex vivo serum analysis revealed an augmented pro-inflammatory response to LPS when microglia cells were cultured with the 7-day LPS serum, indicating the presence of bioactive circulating factors that prime the microglial pro-inflammatory response. Elevated circulating HMGB1 levels were identified in the mouse serum 7 days after LPS administration and in the serum of veterans with GWI. Tail vein injection of rHMGB1 in male C57Bl/6 J mice elevated TNFα mRNA levels in the liver, hippocampus, and cortex, demonstrating HMGB1-induced peripheral and CNS effects. Microglia isolated at 7 days after LPS injection revealed a unique transcriptional profile of 17 genes when compared to the acute 3 H LPS response, 6 of which were also upregulated in the midbrain by rHMGB1, highlighting a distinct signature of the persistent pro-inflammatory microglia phenotype. These findings indicate that circulating HMGB1 is elevated in GWI, regulates the microglial neuroimmune response, and drives chronic neuroinflammation that persists long after the initial instigating peripheral stimulus.


PLoS ONE ◽  
2017 ◽  
Vol 12 (10) ◽  
pp. e0186711
Author(s):  
Yang Chen ◽  
Joel N. Meyer ◽  
Helene Z. Hill ◽  
Gudrun Lange ◽  
Michael R. Condon ◽  
...  

Life Sciences ◽  
2021 ◽  
pp. 119609
Author(s):  
Xueqin Wang ◽  
Noor Ali ◽  
Chien-liang Glenn Lin
Keyword(s):  
Gulf War ◽  

Sign in / Sign up

Export Citation Format

Share Document